The applicant, an ODSP recipient, alleged discrimination on the basis of disability after the respondent denied funding for the drug Phosphate Novartis under the Ontario Drug Benefit Program.
The Tribunal held a summary hearing to determine if the application had a reasonable prospect of success.
The Tribunal found that the applicant failed to allege differential treatment, as he did not claim that others received funding for the drug or that his disability was a factor in the denial.
The application was dismissed for having no reasonable prospect of success.
